Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Return on Equity (2020 - 2025)

Historic Return on Equity for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Q3 2025 value amounting to 0.15%.

  • Mirum Pharmaceuticals' Return on Equity rose 2800.0% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year increase of 2800.0%. This contributed to the annual value of 0.37% for FY2024, which is 4700.0% up from last year.
  • Mirum Pharmaceuticals' Return on Equity amounted to 0.15% in Q3 2025, which was up 2800.0% from 0.24% recorded in Q2 2025.
  • Mirum Pharmaceuticals' 5-year Return on Equity high stood at 0.15% for Q3 2025, and its period low was 2.35% during Q3 2021.
  • For the 5-year period, Mirum Pharmaceuticals' Return on Equity averaged around 0.77%, with its median value being 0.63% (2023).
  • In the last 5 years, Mirum Pharmaceuticals' Return on Equity soared by 20500bps in 2022 and then crashed by -11200bps in 2023.
  • Mirum Pharmaceuticals' Return on Equity (Quarter) stood at 0.95% in 2021, then increased by 9bps to 0.87% in 2022, then grew by 28bps to 0.63% in 2023, then surged by 39bps to 0.38% in 2024, then soared by 61bps to 0.15% in 2025.
  • Its Return on Equity was 0.15% in Q3 2025, compared to 0.24% in Q2 2025 and 0.34% in Q1 2025.